Machine learning method for optimizing coding sequences in mammalian cells.

Mammalian cell lines are the preferred hosts for producing commercially relevant therapeutic proteins such as antibodies, antibody derivatives, and cytokine fusion proteins. Even though significant investment is made to optimize upstream and downstream processes, the optimal gene design parameters for heterologous recombinant protein expression remain poorly understood. We describe a generic approach to gene optimization in which design features are systematically sampled and iteratively modulated using machine learning (ML). Synthetic gene variants encoding the Dasher fluorescent protein, differing only in synonymous codons, were used to interrogate the gene-sequence preferences of transient antibody-expressing HEK293 cells. Synonymous codon variations influenced expression by more than 2 orders of magnitude. This variation in protein yield was used to build ML models relating gene design features, which were then employed to design further-improved genes. The ML models were shown to be expression system-specific. Messenger RNA levels and ribosome occupancy were highly correlated with protein levels, suggesting that mRNA lifetime is influenced by coding bias. Our results illustrate a novel, generally applicable method to improve gene expression via synonymous re-coding for any protein target or host cell.